Wallstreet Hotties of the Day: Abercrombie & Fitch Co. (NYSE:ANF), II-VI Incorporated (NASDAQ:IIVI)

Abercrombie & Fitch Co. (NYSE:ANF)

The shares of Abercrombie & Fitch Co. (NYSE:ANF) started off the last trading session with the price of $22.47 while closing the day with the price of $22.93. The shares of Abercrombie & Fitch Co. (NYSE:ANF) Rise 1.28% with the Gain of 0.46 points.

The shares of Abercrombie & Fitch Co. (NYSE:ANF) traded with the day volume of 1.81 Million shares whereas its average trading volume is 2.73 Million.

While analyzing the past performance of the stock we can see that the shares of Abercrombie & Fitch Co. (NYSE:ANF) Gain 3.52% in the last week while rising 4.61% in the last month. Past quarter performance shows the green light with 37.22%. The semi-annual and annual performance shows 62.86% and 96.49% respectively.

Some critical values of the shares of Abercrombie & Fitch Co. (NYSE:ANF) to be discussed here are: the beta which shows the value at 1.06 while Average True Range of Abercrombie & Fitch Co. (NYSE:ANF) demonstrate the value at 1.05. The weekly and monthly volatility of the shares of Abercrombie & Fitch Co. (NYSE:ANF) are indicated at 3.66% and 4.66%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 60.5.

While studying the financial position of the shares of Abercrombie & Fitch Co. (NYSE:ANF), we can see that the Market capitalization of the company is at 1.57 Billion. The shares outstanding for the company is 68.51 Million and the shares float stands at 67.6 Million. The income of the company stand at 27 Million while the sales stand at 3.49 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.35, Price to Earnings or P/E is at 65.51, Price to Sales P/S show the value of 0.45, the Return on Asset ROA stood at -0.009 and the Return on Equity ROE depicted at -0.017 while Return on Investment ROI is at 0.018.


II-VI Incorporated (NASDAQ:IIVI)

II-VI Incorporated (NASDAQ:IIVI) started its previous trading session at $46.6 and closed at $46.85 showing a Rise of 3.65 Percent.

The Company traded with an average Volume of 902.81 Million whereas, its Day Volume stood at 1.81 Million.

Looking at the performance of the stock, II-VI Incorporated (NASDAQ:IIVI) Gain 12.22% in the last week in its shares price and 22.32% in the last month. Quarterly performance shows a green of 4.23 Percent while Semi-Annual and Annual performances shows a 17.27 and 27.48 percent respectively.

Beta for II-VI Incorporated (NASDAQ:IIVI) stands at 0.15 while the ATR (average true range) is at 1.78. The Stock’s Weekly and Monthly Volatility is 4.97% and 3.62% respectively showing a RSI value of 65.53.

While studying the financial position of the shares of II-VI Incorporated (NASDAQ:IIVI), we can see that the Market capitalization of the company is at 2.99 Billion. The shares outstanding for the company is 63.9 Million and the shares float stands at 55.54 Million.

The Company generated an income of 85.8 Million and the sales of 1.06 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $1.32 a share. P/E (price to earnings) and P/S (price to sales) values are 35.47 and 2.82 respectively.

The Return on Assets stands at 0.056, ROE shows a value of 0.094 and ROI for II-VI Incorporated (NASDAQ:IIVI) is 0.081 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment